Nicholas L. Rider
- Immunology top 5%
- Molecular Biology
- Genetics top 10%
- Clinical Biochemistry top 2%
- Pulmonary and Respiratory Medicine
- Co-authors
- Kevin A. StraussD. Holmes MortonErik G. PuffenbergerChristine HendricksonJordan S. OrangeAnn B. MoserBridget WardleyMichael B. Jameson
- Topics
- Immunodeficiency and Autoimmune Disorders (33 papers)Immune Cell Function and Interaction (8 papers)Cystic Fibrosis Research Advances (7 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEPEDIATRICS
- Partner nations
- United StatesUnited KingdomChile
In The Last Decade
Nicholas L. Rider
52 papers receiving 933 citations
Peers
Comparison fields: 5 of 108
- Immunology 486
- Molecular Biology 253
- Genetics 236
- Clinical Biochemistry 164
- Pulmonary and Respiratory Medicine 112
Countries citing papers authored by Nicholas L. Rider
This map shows the geographic impact of Nicholas L. Rider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas L. Rider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas L. Rider more than expected).
Fields of papers citing papers by Nicholas L. Rider
This network shows the impact of papers produced by Nicholas L. Rider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas L. Rider. The network helps show where Nicholas L. Rider may publish in the future.
Co-authorship network of co-authors of Nicholas L. Rider
This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas L. Rider. A scholar is included among the top collaborators of Nicholas L. Rider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas L. Rider. Nicholas L. Rider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 15 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 6 | |
| 8 | 0 | |
| 9 | 1 | |
| 10 | 0 | |
| 11 | 4 | |
| 12 | 1 | |
| 13 | 4 | |
| 14 | 7 | |
| 15 | 27 | |
| 16 | 3 | |
| 17 | 72 | |
| 18 | 150 | |
| 19 | 33 | |
| 20 | 10 |
About Nicholas L. Rider
Nicholas L. Rider is a scholar working on Immunology, Immunology and Allergy and Health Informatics, having authored 64 papers that have together received 954 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (33 papers), Immune Cell Function and Interaction (8 papers) and Cystic Fibrosis Research Advances (7 papers). The work is most often cited by research in Clinical Biochemistry (164 citations), Immunology (486 citations) and Health Informatics (19 citations). Nicholas L. Rider has collaborated with scholars based in United States, United Kingdom and Chile. Frequent co-authors include Kevin A. Strauss, D. Holmes Morton, Erik G. Puffenberger, Christine Hendrickson, Jordan S. Orange, Ann B. Moser, Bridget Wardley, Michael B. Jameson, C. Buddy Creech and Wilfredo Torres‐Martinez. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.